Product Description: Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
Formula: C13H17NO8
References: [1]Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.